Development and Optimization of a GMP-Compliant Manufacturing Process for a Personalized Tumor Lysate Dendritic Cell Vaccine

With the emergence of immune checkpoint inhibitors and adoptive T-cell therapies, there is a considerable interest in using personalized autologous dendritic cell (DC) vaccines in combination with T cell-targeting immunotherapies to potentially maximize the therapeutic impact of DC vaccines. Here, w...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Vaccines (Basel)
Hlavní autoři: Boudousquié, Caroline, Boand, Valérie, Lingre, Emilie, Dutoit, Laeticia, Balint, Klara, Danilo, Maxime, Harari, Alexandre, Gannon, Philippe O., Kandalaft, Lana E.
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7157441/
https://ncbi.nlm.nih.gov/pubmed/31947581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines8010025
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky